A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications-Reference-Cited by-同舟云学术

A randomised study evaluating the use of pyridoxine to avoid capecitabine dose modifications

Published:2012-07-19 Issue:4 Volume:107 Page:585-587
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Corrie P G,Bulusu R,Wilson C B,Armstrong G,Bond S,Hardy R,Lao-Sirieix S,Parashar D,Ahmad A,Daniel F,Hill M,Wilson G,Blesing C,Moody A M,McAdam K,Osborne M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2012318.pdf

Reference8 articles.

1. Beveridge RA, Kales AN, Binder RA, Miller JA, Virts SG (1990) Pyridoxine (B6) and amelioration of hand/foot syndrome. Proc Am Soc Clin Oncol 9: 102a (abstr 393)

2. Chalermchai T, Tantiphlachiva K, Suwanrusme H, Voravud N, Sriuranpong V (2010) Randomized trial of two different doses of pyridoxine in the prevention of capecitabine-associated palmar-plantar erythrodysesthesia. Asia-Pacific J Clin Oncol 6: 155–160

3. Fabian CJ, Molina R, Slavik M, Dahlberg S, Giri S, Stephens R (1990) Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion. Invest New Drugs 8: 57–63

4. Gressett SM, Stanford BL, Hardwicke F (2006) Management of hand-foot syndrome induced by capecitabine. J Oncol Pharm Pract 12: 131–141

5. Kang YK, Lee SS, Yoon DH, Lee SY, Chun YJ, Kim MS, Ryu MH, Chang HM, Lee JL, Kim TW (2010) Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study. J Clin Oncol 28: 3824–3829

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia;Supportive Care in Cancer;2024-05-14

2. Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells;Cells;2024-01-09

3. Hand-Foot Syndrome in Cancer Patients on Capecitabine: Examining Prevalence, Impacts, and Associated Risk Factors at a Cancer Centre in Malaysia;2023-12-08

4. Chemotherapy-induced hand foot syndrome: comparative efficacy and safety of pharmacological prophylaxis – systematic review and Bayesian network meta-analysis;BMJ Supportive & Palliative Care;2022-12-23

5. Pharmacological prevention strategy for capecitabine‐induced hand‐foot syndrome: A network meta‐analysis of randomized control trials;Dermatologic Therapy;2022-08-30